lysine has been researched along with Hematologic Malignancies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnott, D; Bainer, R; Chan, E; Cheung, T; Flynn, EM; Gascoigne, KE; Haverty, PM; Jeng, E; Jin, L; Kharbanda, S; Magnuson, S; Merchant, M; Raisner, R; Romero, FA | 1 |
| Goyama, S; Huang, G; Kurokawa, M; Mulloy, JC | 1 |
| Dutta, R; Sakamoto, KM; Tiu, B | 1 |
| Allis, CD; Casadio, F; Dormann, HL; Li, H; Luo, JL; Patel, DJ; Song, J; Wang, GG; Wang, Z | 1 |
2 review(s) available for lysine and Hematologic Malignancies
| Article | Year |
|---|---|
Posttranslational modifications of RUNX1 as potential anticancer targets.
Topics: Animals; Antineoplastic Agents; Base Sequence; Carcinogenesis; Core Binding Factor Alpha 2 Subunit; Hematologic Neoplasms; Humans; Lysine; Molecular Sequence Data; Molecular Targeted Therapy; Protein Processing, Post-Translational; Tyrosine | 2015 |
CBP/p300 acetyltransferase activity in hematologic malignancies.
Topics: Acetylation; CREB-Binding Protein; E1A-Associated p300 Protein; Hematologic Neoplasms; Hematopoiesis; Humans; Lysine; Mutation; Transcription, Genetic | 2016 |
2 other study(ies) available for lysine and Hematologic Malignancies
| Article | Year |
|---|---|
Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.
Topics: Acetylation; Binding Sites; Cell Line, Tumor; Chromatin; Enhancer Elements, Genetic; Hematologic Neoplasms; Histones; Humans; Lysine; p300-CBP Transcription Factors; Protein Binding; Protein Domains; Protein Processing, Post-Translational; RNA, Neoplasm; Transcription, Genetic | 2018 |
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.
Topics: Amino Acid Motifs; Animals; Cell Transformation, Neoplastic; Cells, Cultured; Chromatin; Epigenesis, Genetic; Gene Expression Regulation, Developmental; Genes, Homeobox; Hematologic Neoplasms; Hematopoiesis; Hematopoietic Stem Cells; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Magnetic Resonance Spectroscopy; Methylation; Mice; Models, Molecular; Nuclear Pore Complex Proteins; Oncogene Proteins, Fusion; Protein Binding; Protein Conformation; Retinoblastoma-Binding Protein 2; Transcription, Genetic; Tumor Suppressor Proteins | 2009 |